{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T19:16:07Z","timestamp":1785352567101,"version":"3.55.0"},"reference-count":36,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2010,8,1]],"date-time":"2010-08-01T00:00:00Z","timestamp":1280620800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2010,8,1]],"date-time":"2010-08-01T00:00:00Z","timestamp":1280620800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Biochemistry"],"published-print":{"date-parts":[[2010,8]]},"DOI":"10.1016\/j.clinbiochem.2010.05.006","type":"journal-article","created":{"date-parts":[[2010,5,22]],"date-time":"2010-05-22T04:48:07Z","timestamp":1274503687000},"page":"1013-1022","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":22,"title":["USA hCG reference service, 10-year report"],"prefix":"10.1016","volume":"43","author":[{"given":"Laurence A.","family":"Cole","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura L.","family":"Laidler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carolyn Y.","family":"Muller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clinbiochem.2010.05.006_bib1","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1093\/clinchem\/45.2.313","article-title":"False positive hCG levels leading to unnecessary surgery and chemotherapy, and needless occurrences of diabetes and coma","volume":"45","author":"Cole","year":"1999","journal-title":"Clin Chem"},{"key":"10.1016\/j.clinbiochem.2010.05.006_bib2","first-page":"515","article-title":"Falsely elevated hCG leading to unnecessary therapy","volume":"99","author":"Butler","year":"2002","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.clinbiochem.2010.05.006_bib3","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1067\/mob.2003.271","article-title":"Persistent low levels of hCG: a pre-malignant gestational trophoblastic disease","volume":"188","author":"Khanlian","year":"2003","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.clinbiochem.2010.05.006_bib4","first-page":"11","article-title":"Problems with hCG measurements and interpretation of hCG results in gestational trophoblastic diseases","volume":"20","author":"Cole","year":"2003","journal-title":"Jpn J Obstet Gynecol"},{"key":"10.1016\/j.clinbiochem.2010.05.006_bib5","first-page":"150","article-title":"Gestational trophoblastic diseases: 2. Hyperglycosylated hCG as a Reliable Marker of Active Neoplasia","volume":"102","author":"Cole","year":"2006","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.clinbiochem.2010.05.006_bib6","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.ygyno.2005.12.046","article-title":"Gestational trophoblastic diseases: 3. Human Chorionic Gonadotropin Free \u00df-subunit a Reliable Marker of Placental Site Trophoblastic Tumors","volume":"102","author":"Cole","year":"2006","journal-title":"Gyn Oncol"},{"key":"10.1016\/j.clinbiochem.2010.05.006_bib7","first-page":"1","article-title":"hCG tests for managing gestational trophoblastic disease","volume":"50","author":"Cole","year":"2006","journal-title":"J Reprod Med"},{"key":"10.1016\/j.clinbiochem.2010.05.006_bib8","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1056\/NEJMc066500","article-title":"Normal production of hCG in menopause: a medical management dilemma","volume":"356","author":"Cole","year":"2007","journal-title":"N Eng J Med"},{"key":"10.1016\/j.clinbiochem.2010.05.006_bib9","first-page":"457","article-title":"Blood test for placental site trophoblastic tumor (PSTT) and for non-trophoblastic malignancy for evaluating patients with low positive hCG results","volume":"53","author":"Cole","year":"2008","journal-title":"J Reprod Med"},{"key":"10.1016\/j.clinbiochem.2010.05.006_bib10","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.ajog.2007.09.034","article-title":"Detection of hCG peri- or post-menopause an unnecessary source of alarm","volume":"198","author":"Cole","year":"2008","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.clinbiochem.2010.05.006_bib11","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/j.ygyno.2008.09.030","article-title":"The quagmire of hCG and hCG testing in gynecologic oncology","volume":"112","author":"Muller","year":"2009","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.clinbiochem.2010.05.006_bib12","unstructured":"Cole LA, Muller CY, New approach to treating gestational trophoblastic neoplasms. Intl J Gynecol Cancer in press."},{"key":"10.1016\/j.clinbiochem.2010.05.006_bib13","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1016\/S0009-9120(03)00108-5","article-title":"Hyperglycosylated hCG (invasive trophoblast antigen, ITA) a key antigen for early pregnancy detection","volume":"36","author":"Cole","year":"2003","journal-title":"Clin Biochem"},{"key":"10.1016\/j.clinbiochem.2010.05.006_bib14","first-page":"144","article-title":"Gestational trophoblastic diseases: 1. Pathophysiology of hyperglycosylated hCG-regulated neoplasia","volume":"102","author":"Cole","year":"2006","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.clinbiochem.2010.05.006_bib15","first-page":"919","article-title":"Hyperglycosylated hCG (hCG-H) in gestational implantation, and in choriocarcinoma and testicular germ cell malignancy tumorigenesis","volume":"51","author":"Cole","year":"2006","journal-title":"J Reprod Med"},{"key":"10.1016\/j.clinbiochem.2010.05.006_bib16","first-page":"101","article-title":"Use of intact human chorionic gonadotropin and its free alpha- and \u00df-subunit in the detection and management of gynecologic cancers","volume":"68","author":"Cole","year":"1988","journal-title":"Chin J Med"},{"key":"10.1016\/j.clinbiochem.2010.05.006_bib17","first-page":"175","article-title":"Urinary gonadotropin fragment (UGF): A potential \u201cmarker\u201d of colorectal cancer","volume":"5","author":"McGill","year":"1990","journal-title":"J Tumor Marker Oncol"},{"key":"10.1016\/j.clinbiochem.2010.05.006_bib18","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1002\/jso.2930490304","article-title":"Urinary gonadotropin fragment in patients with lung and esophageal disease","volume":"49","author":"D'Agostino","year":"1992","journal-title":"J Surg Oncol"},{"key":"10.1016\/j.clinbiochem.2010.05.006_bib19","doi-asserted-by":"crossref","first-page":"2885","DOI":"10.1073\/pnas.73.8.2885","article-title":"Evidence for a gonadotropin from non-pregnant subjects that has physical, immunological and biological similarities to human chorionic gonadotropin","volume":"73","author":"Chen","year":"1976","journal-title":"Proc Natl Acad Sci"},{"key":"10.1016\/j.clinbiochem.2010.05.006_bib20","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1038\/286740a0","article-title":"Physicochemical and immunological characterization of an hCG-like substance from human pituitary glands","volume":"286","author":"Matsuura","year":"1980","journal-title":"Nature"},{"key":"10.1016\/j.clinbiochem.2010.05.006_bib21","first-page":"245","article-title":"Production of hCG during the menstrual cycle","volume":"54","author":"Cole","year":"2009","journal-title":"J Reprod Med"},{"key":"10.1016\/j.clinbiochem.2010.05.006_bib22","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1016\/j.clinbiochem.2008.10.018","article-title":"The need for a quantitative urine hCG assay","volume":"42","author":"Cole","year":"2009","journal-title":"Clin Biochem"},{"key":"10.1016\/j.clinbiochem.2010.05.006_bib23","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1373\/clinchem.2007.100305","article-title":"Use of serum FSH to identify perimenopausal women with pituitary hCG","volume":"54","author":"Gronowski","year":"2008","journal-title":"Clin Chem"},{"key":"10.1016\/j.clinbiochem.2010.05.006_bib24","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/j.clinbiochem.2004.03.001","article-title":"Easy fix for clinical laboratories for the false positive defect with the Abbott AxSym total \u00df-hCG test","volume":"37","author":"Cole","year":"2004","journal-title":"Clin Biochem"},{"key":"10.1016\/j.clinbiochem.2010.05.006_bib25","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/S0303-7207(02)00135-1","article-title":"Trophoblast origin of hCG isoforms: cytotrophoblasts are the primary source of choriocarcinoma-like hCG","volume":"194","author":"Kovalevskaya","year":"2002","journal-title":"Mol Cell Endocrinol"},{"key":"10.1016\/j.clinbiochem.2010.05.006_bib26","first-page":"5","article-title":"Clinical management of persistent low level hCG elevation","volume":"4","author":"Hancock","year":"2003","journal-title":"Trophobl Dis Upd"},{"key":"10.1016\/j.clinbiochem.2010.05.006_bib27","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1006\/gyno.2002.6622","article-title":"Persistent low-level \u201creal\u201d human chorionic gonadotropin: a clinical challenge and a therapeutic dilemma","volume":"85","author":"Kohorn","year":"2002","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.clinbiochem.2010.05.006_bib28","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1210\/jcem-58-6-1200","article-title":"Differential occurrence of free \u00df and free alpha subunits of human chorionic gonadotropin (hCG)","volume":"58","author":"Cole","year":"1984","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.clinbiochem.2010.05.006_bib29","first-page":"1948","article-title":"A distinctive form of human chorionic gonadotropin \u00df-subunit-like material produced by cervical carcinoma cells","volume":"46","author":"Hussa","year":"1986","journal-title":"Cancer Res"},{"key":"10.1016\/j.clinbiochem.2010.05.006_bib30","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/0090-8258(88)90273-9","article-title":"Urinary gonadotropin fragments (UGF) in cancers of the female reproductive system: I. Sensitivity and specificity, comparison with other markers","volume":"31","author":"Cole","year":"1988","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.clinbiochem.2010.05.006_bib31","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/0090-8258(88)90274-0","article-title":"Urinary gonadotropin fragments (UGF) in cancers of the female reproductive system: II. Initial serial studies","volume":"31","author":"Wong","year":"1988","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.clinbiochem.2010.05.006_bib32","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/0090-8258(90)90148-E","article-title":"Urinary gonadotropin fragment, a new tumor marker: I. Assay development and cancer-specificity","volume":"36","author":"Nam","year":"1990","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.clinbiochem.2010.05.006_bib33","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1093\/glycob\/cwl034","article-title":"Site-specific glycan analysis of human chorionic gonadotropin {beta}-subunit from malignancies and pregnancy by liquid chromatography-electrospray mass spectrometry","volume":"16","author":"Valmu","year":"2006","journal-title":"Glycobiology"},{"key":"10.1016\/j.clinbiochem.2010.05.006_bib34","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1006\/gyno.1999.5438","article-title":"Following metastatic placental site trophoblastic tumor with urine \u03b2-core fragment","volume":"74","author":"Rinne","year":"1999","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.clinbiochem.2010.05.006_bib35","first-page":"643","article-title":"Human chorionic gonadotropin free beta-subunit measurement as a marker of placental site trophoblastic tumors","volume":"53","author":"Harvey","year":"2008","journal-title":"J Reprod Med"},{"key":"10.1016\/j.clinbiochem.2010.05.006_bib36","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1373\/clinchem.2003.026989","article-title":"Between-method variation in hCG test results","volume":"50","author":"Cole","year":"2004","journal-title":"Clin Chem"}],"container-title":["Clinical Biochemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009912010002407?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009912010002407?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,14]],"date-time":"2025-09-14T15:33:27Z","timestamp":1757864007000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0009912010002407"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,8]]},"references-count":36,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2010,8]]}},"alternative-id":["S0009912010002407"],"URL":"https:\/\/doi.org\/10.1016\/j.clinbiochem.2010.05.006","relation":{},"ISSN":["0009-9120"],"issn-type":[{"value":"0009-9120","type":"print"}],"subject":[],"published":{"date-parts":[[2010,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"USA hCG reference service, 10-year report","name":"articletitle","label":"Article Title"},{"value":"Clinical Biochemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clinbiochem.2010.05.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2010 The Canadian Society of Clinical Chemists. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}